A pilot study of use of the cyclooxygenase-2 inhibitor celecoxib in recurrent prostate cancer after definitive radiation therapy or radical prostatectomy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A pilot study of use of the cyclooxygenase-2 inhibitor celecoxib in recurrent prostate cancer after definitive radiation therapy or radical prostatectomy

Published:2004-02 Issue:3 Volume:93 Page:275-278
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Pruthi R.S.,Derksen J.E.,Moore D.

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2004.04601.x/fullpdf

Reference21 articles.

1. Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors

2. INHIBITION OF CYCLOOXYGENASE-2 SUPPRESSES ANGIOGENESIS AND THE GROWTH OF PROSTATE CANCER IN VIVO

3. COX-2 is expressed in human pulmonary, colonic, and mammary tumors

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Potential Preventive and Therapeutic Roles of NSAIDs in Prostate Cancer;Cancers;2023-11-16

2. Druggable Metabolic Vulnerabilities Are Exposed and Masked during Progression to Castration Resistant Prostate Cancer;Biomolecules;2022-10-28

3. Intraprostatic Chronic Inflammation is Associated with a Reduced Risk of Prostate Cancer in Patients Elected to a First Random Biopsy Set;Tumori Journal;2016-09-11

4. Phase II trial of weekly Docetaxel, Zoledronic acid, and Celecoxib for castration-resistant prostate cancer;Investigational New Drugs;2016-05-10

5. Analgesic use — prevalence, biomonitoring and endocrine and reproductive effects;Nature Reviews Endocrinology;2016-05-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP